{
  "report_rows": [
    {
      "kpi": "Adj. Operating Margin (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~24.5% vs. cons 24.11%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Organic Growth (Q2 2026)",
      "prediction": "IN-LINE",
      "answer": "pred ~9.5% vs. cons ~8.8%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS Diluted (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$5.52 vs. cons $5.38",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY 2026 Organic Growth (FY)",
      "prediction": "BETTER",
      "answer": "guide ~8.5% midpoint vs. cons ~8.1%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Adj. EPS (FY)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$19.85 midpoint vs. cons $19.84",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY 2026 Adj. Op. Margin (FY)",
      "prediction": "UNCHANGED",
      "answer": "guide ~23.0% vs. cons 23.03%",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 3.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 sell-side H2 EPS revisions driven by FY organic raise and implied H2 math (+7% above Street); partially offset by pre-print run already consuming some upside",
  "day5_confidence": "MEDIUM"
}